| 2022-11-14 |
详情>>
股本变动：
变动后总股本799.98万股
变动原因 ▼▲
- 原因：
- From June 30, 2022 to September 30, 2022
Restricted share units vested
Payment of interest in shares
|
| 2022-11-14 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-3.65美元,归母净利润-2501.7万美元,同比去年增长-60.65%
|
| 2022-11-14 |
财报披露：
美东时间 2022-11-14 盘后发布财报
|
| 2022-08-15 |
详情>>
业绩披露：
2022年中报每股收益-2.97美元,归母净利润-1891.9万美元,同比去年增长-93.35%
|
| 2022-08-02 |
股东大会：
将于2022-08-31召开股东大会
会议内容 ▼▲
- 1.To elect six directors, as described in the accompanying proxy statement, to serve until the next annual meeting of shareholders or until their successors are elected;
2.To approve the compensation to our Chief Executive Officer;
3.To approve our amended executive compensation policy (the “Compensation Policy”) and the compensation to our non-employee Directors in accordance with the amended Compensation Policy;
4.To approve the Amended and Restated 2016 Equity Incentive Plan and respective Israeli Appendix;
5.To approve the Amended and Restated 2016 Non-Employee Director Equity Incentive Plan and respective Israeli Appendix;
6.To ratify and approve the re-appointment of Kost, Forer, Gabbay & Kasierer (a member firm of Ernst & Young Global) as our independent registered public accountants for the year ending December 31, 2022 and for the year commencing January 1, 2023 and until the next annual meeting of shareholders and to authorize our Board of Directors and Audit Committee to determine its fees;
7.To approve, on an advisory basis, the compensation of our named executive officers;
8.To review and discuss our consolidated financial statements for the fiscal year ended December 31, 2021;
9.To transact such other business as may properly come before the Annual Meeting and any adjournment or postponement of the Annual Meeting.
|
| 2022-05-16 |
详情>>
业绩披露：
2022年一季报每股收益-1.3美元,归母净利润-648.3万美元,同比去年增长-54.47%
|
| 2022-03-24 |
详情>>
业绩披露：
2021年年报每股收益-5.9美元,归母净利润-2303.9万美元,同比去年增长-33.46%
|
| 2022-03-09 |
复牌提示：
2022-03-08 14:42:49 停牌，复牌日期 2022-03-08 14:47:49
|
| 2022-02-09 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2022-01-05 |
股东大会：
将于2022-02-07召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our Articles of Association to effect a reverse split of our ordinary shares par value ILS 0.15 each (the “Ordinary Shares”) at a ratio of not less than 1 for 4 and not greater than 1 for 20, effective on a date to be determined by our board of directors (our “Board”), no later than 30 days following the date of the Special Meeting;
2.subject to the approval of Proposal One, to approve an increase of our authorized share capital and in the number of our authorized Ordinary Shares, and to amend our Articles of Association accordingly;
3.to transact such other business as may properly come before the Special Meeting and any adjournment or postponement of the Special Meeting.
|
| 2021-11-15 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-0.21美元,归母净利润-1557.2万美元,同比去年增长-27.05%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-16 |
详情>>
业绩披露：
2021年中报每股收益-0.14美元,归母净利润-978.5万美元,同比去年增长-32.86%
|
| 2021-06-03 |
股东大会：
将于2021-07-08召开股东大会
会议内容 ▼▲
- 1.to elect seven directors, as described in the accompanying proxy statement, to serve until the next annual meeting of shareholders or until their successors are elected;
2.to approve an increase in the number of our authorized share capital and authorized Ordinary Shares, and to amend our Articles of Association accordingly;
3.to approve our revised executive compensation policy with respect to the terms of office and employment of our officers (the “Executive Compensation Policy”), in accordance with the requirements of the Israeli Companies Law 5759-1999;
4.to approve the award of RSU’s to our non-employee directors;
5.to ratify and approve the re-appointment of Kost, Forer, Gabbay & Kasierer (a member firm of Ernst & Young Global) as our independent registered public accountants for the year ending December 31, 2021 and for the year commencing January 1, 2022 and until the next annual meeting of shareholders and to authorize our Board of Directors and Audit Committee to determine its fees;
6.to approve, on an advisory basis, the compensation of our named executive officers;
7.to review and discuss our consolidated financial statements for the fiscal year ended December 31, 2020;
8.to transact such other business as may properly come before the Annual Meeting and any adjournment or postponement of the Annual Meeting.
|
| 2021-05-17 |
详情>>
业绩披露：
2021年一季报每股收益-0.06美元,归母净利润-419.7万美元,同比去年增长-52.56%
|
| 2021-03-30 |
详情>>
业绩披露：
2020年年报每股收益-0.29美元,归母净利润-1726.3万美元,同比去年增长4.19%
|
| 2020-11-16 |
详情>>
业绩披露：
2020年三季报(累计)每股收益-0.2美元,归母净利润-1225.7万美元,同比去年增长3.33%
|
| 2020-08-12 |
详情>>
业绩披露：
2020年中报每股收益-0.12美元,归母净利润-736.5万美元,同比去年增长19.50%
|
| 2020-06-25 |
股东大会：
将于2020-07-30召开股东大会
会议内容 ▼▲
- 1.to elect nine directors, as described in the accompanying proxy statement, to serve until the next annual meeting of shareholders or until their successors are elected;
2.to approve the compensation to our Chairman of the Board;
3.to approve the equity-based compensation to our Chief Executive Officer;
4.to approve, as required by Nasdaq Listing Rule 5635(d), the issuance of more than 19.99% of our outstanding ordinary shares in connection with our 5.75% Convertible Debentures due 2024;
5.to ratify and approve the re-appointment of Kost, Forer, Gabbay & Kasierer (a member firm of Ernst & Young Global) as our independent registered public accountants for the year ending December 31, 2020 and for the year commencing January 1, 2021 and until the next annual meeting of shareholders and to authorize our Board of Directors and Audit Committee to determine its fees;
6.to approve, on an advisory basis, the compensation of our named executive officers;
7.to review and discuss our consolidated financial statements for the fiscal year ended December 31, 2019;
8.to transact such other business as may properly come before the Annual Meeting and any adjournment or postponement of the Annual Meeting.
|
| 2019-06-25 |
股东大会：
将于2019-07-30召开股东大会
会议内容 ▼▲
- 1.to elect eight directors, as described in the accompanying proxy statement, to serve until the next annual meeting of shareholders or until their successors are elected;
2.to elect two External Directors to each serve for a three-year term;
3.to approve the compensation to our Chairman of the Board;
4.to approve amendments to the terms of compensation to our non-executive directors;
5.to approve an increase in the number of Ordinary Shares reserved for issuance under our 2016 Equity Incentive Plan and respective Israeli Appendix;
6.to approve an increase in the number of Ordinary Shares reserved for issuance under our 2016 Non-Employee Director Equity Incentive Plan and respective Israeli Appendix;
7.to approve an increase in the number of our authorized Ordinary Shares and authorized share capital, and to amend our Articles of Association to reflect such increase;
8.to ratify and approve the re-appointment of Kost, Forer, Gabbay & Kasierer (a member firm of Ernst & Young Global) as our independent public accountants for the year ending December 31, 2019 and for the year commencing January 1, 2020 and until the next annual meeting of shareholders and to authorize our Board of Directors and Audit Committee to determine its fees;
9.to approve, on an advisory basis, the compensation of our named executive officers;
10.to approve, on an advisory basis, the frequency of future advisory votes on the compensation of our named executive officers;
11.to review and discuss our consolidated financial statements for the fiscal year ended December 31, 2018;
12.to transact such other business as may properly come before the Annual Meeting and any adjournment or postponement of the Annual Meeting.
|
| 2019-01-22 |
详情>>
内部人交易：
Becker John Charles等共交易9笔
|
| 2018-07-02 |
股东大会：
将于2018-08-28召开股东大会
会议内容 ▼▲
- 1.to elect eight Directors, six of whom are continuing Directors (including the Chairman of the Board and CEO and including two directors that are nominees of and affiliated with the Company’s controlling shareholder (WP XII Investments BV, an entity controlled by funds affiliated with Warburg Pincus LLC) and two nominees that are nominees of and affiliated with the Company’s controlling shareholder, to serve for the ensuing year or until their successors are elected;
2.To approve certain amendments to the Company’s Amended and Restated Articles of Association;
3.To approve the entry into indemnification and exculpation agreements with the Company’s directors and officers;
4.To approve the Company’s new compensation policy with respect to the terms of office and employment of the Company’s office holders (the “New Compensation Policy”), in accordance with the requirements of the Israeli Companies Law 5759-1999;
5.To approve the grant of 275,000 options to purchase ordinary shares of the Company to Mr. Lior Samuelson, the Company’s Chief Executive Officer and Chairman of the Board;
6.To ratify and approve the re-appointment of Kost, Forer, Gabbay & Kasierer (a member firm of Ernst & Young Global) as the Company’s independent public accountants for the year ending December 31, 2018 and for the year commencing January 1, 2019 and until the next annual meeting of the Company’s shareholders and to authorize the Company’s Board and Audit Committee to determine its fees;
7.To review and discuss the Company’s consolidated financial statements for the fiscal year ended December 31, 2017.
|
| 2017-11-17 |
股东大会：
将于2017-12-28召开股东大会
会议内容 ▼▲
- 1.to elect seven Directors, five of whom are continuing Directors and two of whom are nominees of and affiliated with the Company's new investor pursuant to the WP SPA (as defined below), including the Chairman of the Board and CEO, to serve for the ensuing year or until their successors are elected;
2.to ratify and approve the re-appointment of Kost, Forer, Gabbay & Kasierer (a member firm of Ernst & Young Global) as the Company’s independent public accountants for the year ending December 31, 2017 and for the year commencing January 1, 2018 and until the next annual meeting of the Company's shareholders and to authorize the Company's Board and Audit Committee to determine its fees;
3.to review and discuss the Company’s consolidated financial statements for the fiscal year ended December 31, 2016.
|
| 2016-11-17 |
股东大会：
将于2016-12-22召开股东大会
会议内容 ▼▲
- 1.to re-elect five continuing Directors, including the Chairman of the Board and CEO, to serve for the ensuing year or until their successors are elected;
2.to elect Mr. John Becker as one of the Outside Directors of the Company for an initial three year term, commencing on April 1, 2017 and to approve his remuneration as an Outside Director of the Company;
3.to approve the Company's 2016 Non-Employee Director Equity Incentive Plan and respective Israeli Appendix and the 2016 Equity Incentive Plan and respective Israeli Appendix and the number of Ordinary Shares reserved for issuance under each such plans;
4.to approve an increase in the number of the Company’s authorized ordinary shares and authorized share capital, and to amend the Articles of Association of the Company to reflect such increase;
5.to re-appoint Kost, Forer, Gabbay & Kasierer (a member firm of Ernst & Young Global) as the Company’s independent public accountants for the 2016 audit services and 2017 limited procedures and to approve its compensation;
6.to review and discuss the Company’s consolidated financial statements for the fiscal year ended December 31, 2015.
|
| 2015-11-02 |
股东大会：
将于2015-12-08召开股东大会
会议内容 ▼▲
- 1.To re-elect five continuing Directors, including the Chairman of the Board and CEO, to serve for the ensuing year or until their successors are elected;
2.To re-elect one Outside Director to serve for a term of three years;
3.To approve the Company’s amended executive compensation policy;
4.To re-appoint Kost, Forer, Gabbay & Kasierer (a member firm of Ernst & Young Global) as the Company’s independent public accountants for the 2015 audit services and 2016 limited procedures and to approve its compensation;
5.To review and discuss the Company’s consolidated financial statements for the fiscal year ended December 31, 2014.
|
| 2014-11-10 |
股东大会：
将于2014-12-18召开股东大会
会议内容 ▼▲
- 1.to re-elect five continuing Directors, including the Chairman of the Board and CEO, to serve for the ensuing year or until their successors are elected;
2.to approve the Company’s amended executive compensation policy;
3.to re-appoint Kost, Forer, Gabbay & Kasierer (a member firm of Ernst & Young Global) as the Company’s independent public accountants for 2014 and to approve its compensation;
4.to review and discuss the Company’s consolidated financial statements for the fiscal year ended December 31, 2013.
|
| 2014-01-07 |
股东大会：
将于2014-01-29召开股东大会
会议内容 ▼▲
- 1. TO VOTE ON THE PROPOSAL TO APPROVE a change of the Company's name to CYREN Ltd. or such similar name containing the name “CYREN” as determined by the Company's management and approved by the Israeli Registrar of Companies, and approve the applicable amendments to the Company's Memorandum of Association and Articles of Association to reflect such name change (the change of the Company’s name will be effective only following the approval and authorization of the Israeli Registrar of Companies).
|
| 2013-11-19 |
股东大会：
将于2013-12-24召开股东大会
会议内容 ▼▲
- 1. to re-elect six continuing Directors to serve for the ensuing year or until their successors are elected;
2. to re-elect one Outside Director to serve for a term of three years;
3. to approve the appointment of Mr. Lior Samuelson, Chairman of the Board, as CEO of the Company, and to approve his compensation;
4. to re-appoint Kost, Forer, Gabbay & Kasierer (a member firm of Ernst & Young Global) as the Company’s independent public accountants for 2013 and to approve its compensation;
5. to review and discuss the Company’s consolidated financial statements for the fiscal year ended December 31, 2012.
|
| 2012-11-09 |
股东大会：
将于2012-12-13召开股东大会
会议内容 ▼▲
- 1.to re-elect five continuing Directors and elect one new Director to serve for the ensuing year or until their successors are elected
2.subject to his election as a Director, to approve the compensation terms of our Chief Executive Officer
3.to ratify the appointment and compensation of Kost, Forer, Gabbay & Kasierer (a member firm of Ernst & Young Global) as the Company’s independent public accountants for 2012
4.to review and discuss the Company’s consolidated financial statements for the fiscal year ended December 31, 2011.
|